MedLumics is Proud to Announce the Completion of the FIM Study, With Successful Remapping at 3 Months, Demonstrating the Efficacy of the AblaView® Optically Guided Pulsed Field Ablation (PFA) System and Presentation at the AF Symposium 2025
MADRID, December 19, 2024–(BUSINESS WIRE)–“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm the success of ablation under direct vision in real time” Peter Hinchliffe, CEO MedLumics The results of this clinical investigation will be presented in Boston at … Read more